These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 36567199)

  • 21. CSPα reduces aggregates and rescues striatal dopamine release in α-synuclein transgenic mice.
    Caló L; Hidari E; Wegrzynowicz M; Dalley JW; Schneider BL; Podgajna M; Anichtchik O; Carlson E; Klenerman D; Spillantini MG
    Brain; 2021 Jul; 144(6):1661-1669. PubMed ID: 33760024
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Native α-synuclein induces clustering of synaptic-vesicle mimics via binding to phospholipids and synaptobrevin-2/VAMP2.
    Diao J; Burré J; Vivona S; Cipriano DJ; Sharma M; Kyoung M; Südhof TC; Brunger AT
    Elife; 2013 Apr; 2():e00592. PubMed ID: 23638301
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is Cell Death Primary or Secondary in the Pathophysiology of Idiopathic Parkinson's Disease?
    Schulz-Schaeffer WJ
    Biomolecules; 2015 Jul; 5(3):1467-79. PubMed ID: 26193328
    [TBL] [Abstract][Full Text] [Related]  

  • 24. α-Synuclein pathology in Parkinson's disease and related α-synucleinopathies.
    Henderson MX; Trojanowski JQ; Lee VM
    Neurosci Lett; 2019 Sep; 709():134316. PubMed ID: 31170426
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Snaring the function of alpha-synuclein.
    Bonini NM; Giasson BI
    Cell; 2005 Nov; 123(3):359-61. PubMed ID: 16269324
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanisms of α-Synuclein Induced Synaptopathy in Parkinson's Disease.
    Bridi JC; Hirth F
    Front Neurosci; 2018; 12():80. PubMed ID: 29515354
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alpha-synuclein and intracellular trafficking: impact on the spreading of Parkinson's disease pathology.
    Eisbach SE; Outeiro TF
    J Mol Med (Berl); 2013 Jun; 91(6):693-703. PubMed ID: 23616088
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impaired dopamine storage resulting from alpha-synuclein mutations may contribute to the pathogenesis of Parkinson's disease.
    Lotharius J; Brundin P
    Hum Mol Genet; 2002 Oct; 11(20):2395-407. PubMed ID: 12351575
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A systematic RNAi screen reveals involvement of endocytic pathway in neuronal dysfunction in alpha-synuclein transgenic C. elegans.
    Kuwahara T; Koyama A; Koyama S; Yoshina S; Ren CH; Kato T; Mitani S; Iwatsubo T
    Hum Mol Genet; 2008 Oct; 17(19):2997-3009. PubMed ID: 18617532
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lipid vesicles affect the aggregation of 4-hydroxy-2-nonenal-modified α-synuclein oligomers.
    Sardar Sinha M; Villamil Giraldo AM; Öllinger K; Hallbeck M; Civitelli L
    Biochim Biophys Acta Mol Basis Dis; 2018 Sep; 1864(9 Pt B):3060-3068. PubMed ID: 29960040
    [TBL] [Abstract][Full Text] [Related]  

  • 31. NK cells clear α-synuclein and the depletion of NK cells exacerbates synuclein pathology in a mouse model of α-synucleinopathy.
    Earls RH; Menees KB; Chung J; Gutekunst CA; Lee HJ; Hazim MG; Rada B; Wood LB; Lee JK
    Proc Natl Acad Sci U S A; 2020 Jan; 117(3):1762-1771. PubMed ID: 31900358
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alpha-Synuclein and Lipids: The Elephant in the Room?
    Sarchione A; Marchand A; Taymans JM; Chartier-Harlin MC
    Cells; 2021 Sep; 10(9):. PubMed ID: 34572099
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Overcrowded Crossroads: Mitochondria, Alpha-Synuclein, and the Endo-Lysosomal System Interaction in Parkinson's Disease.
    Lin KJ; Lin KL; Chen SD; Liou CW; Chuang YC; Lin HY; Lin TK
    Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31731450
    [TBL] [Abstract][Full Text] [Related]  

  • 34. α-Synuclein A30P decreases neurodegeneration and increases synaptic vesicle release probability in CSPα-null mice.
    Ruiz R; Biea IA; Tabares L
    Neuropharmacology; 2014 Jan; 76 Pt A():106-17. PubMed ID: 24036317
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Docosahexaenoic acid promotes vesicle clustering mediated by alpha-Synuclein via electrostatic interaction.
    Tyoe O; Aryal C; Diao J
    Eur Phys J E Soft Matter; 2023 Oct; 46(10):96. PubMed ID: 37823961
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sigma-2 receptor antagonists rescue neuronal dysfunction induced by Parkinson's patient brain-derived α-synuclein.
    Limegrover CS; Yurko R; Izzo NJ; LaBarbera KM; Rehak C; Look G; Rishton G; Safferstein H; Catalano SM
    J Neurosci Res; 2021 Apr; 99(4):1161-1176. PubMed ID: 33480104
    [TBL] [Abstract][Full Text] [Related]  

  • 37. From α-synuclein to synaptic dysfunctions: new insights into the pathophysiology of Parkinson's disease.
    Bellucci A; Zaltieri M; Navarria L; Grigoletto J; Missale C; Spano P
    Brain Res; 2012 Oct; 1476():183-202. PubMed ID: 22560500
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vesicle trafficking and lipid metabolism in synucleinopathy.
    Fanning S; Selkoe D; Dettmer U
    Acta Neuropathol; 2021 Apr; 141(4):491-510. PubMed ID: 32607605
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Physiological roles of α-synuclein serine-129 phosphorylation - not an oxymoron.
    Ramalingam N; Haass C; Dettmer U
    Trends Neurosci; 2024 Jul; 47(7):480-490. PubMed ID: 38862330
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Role of Membrane Affinity and Binding Modes in Alpha-Synuclein Regulation of Vesicle Release and Trafficking.
    Das T; Ramezani M; Snead D; Follmer C; Chung P; Lee KY; Holowka DA; Baird BA; Eliezer D
    Biomolecules; 2022 Dec; 12(12):. PubMed ID: 36551244
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.